Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape
that allows their assignment to clusters based on underlying genetic alterations. With around …

Molecular targeted therapy plays an increasingly important role in the treatment of metastatic
pheochromocytomas and paragangliomas (PPGLs), which are rare tumors but remain …

Abstract Context Pheochromocytomas and paragangliomas (PPGLs) are believed to harbor
malignant potential; about 10% to 15% of pheochromocytomas and up to 50% of abdominal …

The genetics of pheochromocytoma and paraganglioma (PPGL) has become increasingly
complex over the last two decades. The list of genes involved in the development of these …

Pheochromocytomas (PCC) and paragangliomas (PGL) are rare neuroendocrine tumors.
Pheochromocytomas arise from chromaffin cells in the adrenal medulla, and PGLs arise …

Simple Summary Pheochromocytomas and abdominal paragangliomas (PPGLs) are rare.
They can be discovered incidentally by imaging with computed tomography or magnetic …

Objective To offer a practical guide for the presurgical and anesthetic management of
pheochromocytomas and sympathetic paragangliomas (PGLs). Methods This protocol was …

Purpose Pheochromocytoma crisis is a life-threatening endocrine emergency that requires
prompt diagnosis and treatment. Because of its rarity, sudden onset, and lack of …

Pheochromocytomas (PCCs) are rare neuroendocrine tumors derived from the chromaffin
cells of the adrenal medulla. When these tumors have an extra‐adrenal location, they are …

Objective The aim of this review is to provide a practical approach for clinicians regarding
the diagnosis and management of pheochromocytomas and paragangliomas (PPGL) …